Guangzhou Wondfo Biotech Co Ltd Total Assets

Latest as of March 2026: CN¥6.73 Billion CNY ≈ $985.42 Million USD

Guangzhou Wondfo Biotech Co Ltd total assets. Based on the latest financial reports, Guangzhou Wondfo Biotech Co Ltd (300482) holds total assets worth CN¥6.73 Billion CNY (≈ $985.42 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 300482 stock market capitalisation for the company's overall valuation and market capitalisation.

Total Assets of Guangzhou Wondfo Biotech Co Ltd (2011–2025)

Total assets of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025. This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's total assets have evolved over time, based on quarterly financial data. See latest Guangzhou Wondfo Biotech Co Ltd stock price today for real-time trading data and today's change.

Guangzhou Wondfo Biotech Co Ltd - Asset Composition Analysis

Guangzhou Wondfo Biotech Co Ltd Total Assets Breakdown (December 2025)

Guangzhou Wondfo Biotech Co Ltd total assets breakdown as of December 2025. Guangzhou Wondfo Biotech Co Ltd's total assets of CN¥6.73 Billion consist of 50.0% current assets and 50.0% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	7.0%
Accounts Receivable	CN¥774.19 Million	11.7%
Inventory	CN¥280.58 Million	4.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥275.93 Million	4.2%
Goodwill	CN¥108.97 Million	1.7%

Asset Composition Trend (2011–2025)

This chart illustrates how Guangzhou Wondfo Biotech Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Guangzhou Wondfo Biotech Co Ltd to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Guangzhou Wondfo Biotech Co Ltd's current assets represent 50.0% of total assets in 2025, a decrease from 51.9% in 2011.
Cash Position: Cash and equivalents constituted 7.0% of total assets in 2025, down from 12.0% in 2011.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, an increase from 4.0% in 2011.
Asset Diversification: The largest asset category is accounts receivable at 11.7% of total assets.

Guangzhou Wondfo Biotech Co Ltd Competitors by Total Assets

Key competitors of Guangzhou Wondfo Biotech Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Shenzhen New Industries Biomedical SHE:300832	China	CN¥9.58 Billion
Double Medical Technology Inc SHE:002901	China	CN¥5.03 Billion
BMC Medical Co. Ltd. A SHE:301367	China	CN¥3.59 Billion
SS Innovations International Inc. Common Stock NASDAQ:SSII	USA	$96.98 Million
Emvision Medical Devices Ltd AU:EMV	Australia	AU$24.94 Million
Sequana Medical NV BR:SEQUA	Belgium	€14.57 Million
Hironic Co. Ltd KQ:149980	Korea	₩80.01 Billion
DRGEM Corporation KQ:263690	Korea	₩131.65 Billion

Guangzhou Wondfo Biotech Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	3.22	5.78	3.25
Quick Ratio	2.97	5.30	2.67
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥2.38 Billion	CN¥3.16 Billion	CN¥1.94 Billion

Guangzhou Wondfo Biotech Co Ltd - Advanced Valuation Insights

This section examines the relationship between Guangzhou Wondfo Biotech Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.74
Latest Market Cap to Assets Ratio	0.17
Asset Growth Rate (YoY)	-7.7%
Total Assets	CN¥6.60 Billion
Market Capitalization	$1.10 Billion USD

Valuation Analysis

Below Book Valuation: The market values Guangzhou Wondfo Biotech Co Ltd's assets below their book value (0.17x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Guangzhou Wondfo Biotech Co Ltd's assets decreased by 7.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Guangzhou Wondfo Biotech Co Ltd (2011–2025)

The table below shows the annual total assets of Guangzhou Wondfo Biotech Co Ltd from 2011 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥6.60 Billion ≈ $966.03 Million	-7.73%
2024-12-31	CN¥7.15 Billion ≈ $1.05 Billion	+23.96%
2023-12-31	CN¥5.77 Billion ≈ $844.58 Million	-8.40%
2022-12-31	CN¥6.30 Billion ≈ $922.05 Million	+29.76%
2021-12-31	CN¥4.86 Billion ≈ $710.56 Million	+12.77%
2020-12-31	CN¥4.31 Billion ≈ $630.12 Million	+46.27%
2019-12-31	CN¥2.94 Billion ≈ $430.80 Million	+9.38%
2018-12-31	CN¥2.69 Billion ≈ $393.85 Million	+58.81%
2017-12-31	CN¥1.69 Billion ≈ $248.00 Million	+68.51%
2016-12-31	CN¥1.01 Billion ≈ $147.17 Million	+25.94%
2015-12-31	CN¥798.57 Million ≈ $116.86 Million	+94.83%
2014-12-31	CN¥409.88 Million ≈ $59.98 Million	+21.86%
2013-12-31	CN¥336.35 Million ≈ $49.22 Million	+11.15%
2012-12-31	CN¥302.61 Million ≈ $44.28 Million	+15.44%
2011-12-31	CN¥262.13 Million ≈ $38.36 Million	--

About Guangzhou Wondfo Biotech Co Ltd

SHE:300482 China Medical Devices

Market Cap

$1.10 Billion

CN¥7.54 Billion CNY

Market Cap Rank

#8155 Global

#1798 in China

Share Price

CN¥16.11

Change (1 day)

-0.06%

52-Week Range

CN¥15.55 - CN¥25.56

All Time High

CN¥92.01